Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity.

[1]  I. Ahmad,et al.  Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro. , 1992, Cancer research.

[2]  M. C. Popescu,et al.  Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity. , 1992, Biochimica et biophysica acta.

[3]  Janoff As.  Lipids, liposomes, and rational drug design. , 1992 .

[4]  Wayne L. Smith,et al.  Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. , 1992, The Journal of biological chemistry.

[5]  H. Kamaya,et al.  Depression of phase-transition temperature by anesthetics: nonzero solid membrane binding. , 1988, Biochimica et biophysica acta.

[6]  F. Szoka,et al.  Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B , 1987, Antimicrobial Agents and Chemotherapy.

[7]  H. Galla,et al.  Partition of chlorpromazine into lipid bilayer membranes: the effect of membrane structure and composition. , 1986, Biochimica et biophysica acta.

[8]  L. Mayer,et al.  Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. , 1985, Biochimica et biophysica acta.

[9]  E. Hersh,et al.  Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. , 1983, The Journal of infectious diseases.

[10]  A. Helenius,et al.  Solubilization of membranes by detergents. , 1975, Biochimica et biophysica acta.

[11]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.